Johnson, Eugenie Evelynne https://orcid.org/0000-0003-3324-7141
Orozco-Leal, Giovany https://orcid.org/0000-0002-7473-7318
Al-Assaf, Aalya https://orcid.org/0009-0005-8689-2162
Wu, Hangjian https://orcid.org/0000-0001-8377-3276
Agbeleye, Opeyemi https://orcid.org/0009-0008-6529-427X
Hosseini-Jebeli, Sedighe https://orcid.org/0000-0001-9448-2685
Sotire, Tumi https://orcid.org/0000-0002-5330-9568
Dobson, Emma https://orcid.org/0000-0002-1300-5607
Wallace, Sheila A. https://orcid.org/0000-0003-2853-3653
Pearson, Fiona
Rice, Stephen https://orcid.org/0000-0002-6767-0813
Funding for this research was provided by:
Evidence Synthesis Programme (NIHR135664)
Article History
Accepted: 13 July 2025
First Online: 9 August 2025
Declarations
:
: The independent EAG report was commissioned by the National Institute for Health and Care Research Evidence Synthesis Programme as project number NIHR135664. See the Health Technology Assessment programme website for further project information (). This summary of the EAG report was compiled after NICE issued the Final Appraisal Determination. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of NICE or the Department of Health and Social Care.
: Eugenie Evelynne Johnson, Giovany Orozco-Leal, Aalya Al-Assaf, Hangjian Wu, Opeyemi Agbeleye, Sedighe Hosseini-Jebeli, Tumi Sotire, Emma Dobson, Sheila A. Wallace, Fiona Pearson and Stephen Rice have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design and were involved with the work of the EAG. The manuscript was written by EEJ and GO-L. All authors were involved in the critical review of the clinical and cost-effectiveness evidence, drafting of the EAG report, and providing critical feedback on the manuscript. All authors approved the final version.